Study of VESIcare® In Overactive Bladder (OAB) Subjects to Evaluate Symptom Bother and Health Related Quality of Life

NCT00573508 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

768

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Bladder, Overactive

Interventions

DRUG: Placebo
DRUG: Solifenacin Succinate

Sponsor

Astellas Pharma Inc